Colchicine — Drug Intelligence | 26 EU Trials

Filter these 26 trials by condition, phase, country and more.

Open in Search →

26 Registered trials

13 Recruiting

5 Completed trials

18 Sponsors

12 Countries

Phase III

Phase II

Phase III: 15 Phase II: 8 Phase III/IV: 1 Phase IV: 2

Oversight events:

1 serious breach 1 temporary halt 2 urgent safety measures 1 unexpected event 1 corrective measure across 5 trials

View oversight register →

Indications tested

Arterial stiffness 1 Type 1 diabetes mellitus 1 Gout 1 Coronary artery disease 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 3 Gentofte Hospital 3 Radboud universitair medisch centrum Stichting 3 Hamilton Health Sciences Corporation 2 Region Hovedstaden 2 Universitair Medisch Centrum Utrecht 2 ASST Grande Ospedale Metropolitano Niguarda 1 Az St-Jan Brugge-Oostende A.V. 1 Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia 1 Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz 1 Goethe University Frankfurt 1 Montreal Heart Institute 1

All trials

26 total

RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Not authorised

2024-511580-28-00 Phase III 1 country Universitair Medisch Centrum Utrecht
Research into existing medicines to reduce aging, pain, and inflammation in osteoarthritis. Not authorised

2025-524885-12-00 Phase II 1 country Radboud universitair medisch centrum Stichting
Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial Pending

2024-513486-39-00 Phase III 1 country Stichting Radboud universitair medisch centrum
Single-blinded randomized investigator-initiated controlled trial to assess the efficacy of colchicine to treat patients with cardiomyopathy… Pending

2024-517945-14-00 Phase III 1 country ASST Grande Ospedale Metropolitano Niguarda
Randomized, controlled, double-blind trial to investigate the effect of colchicin on the endothelial function in patients with CHIP mutation… Pending

2024-518383-12-00 Phase II 1 country Goethe University Frankfurt
Clinical trial of colchicine to reduce coronary artery inflammation in people with HIV. Pending

2024-520346-39-00 Phase II 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
Study on the use of colchicine to reduce inflammation after deep vein thrombosis Pending

2025-521836-12-00 Phase II 1 country Universita' Degli Studi G. D'Annunzio Di Chieti
CALIBRATE Pending

2026-525547-32-01 Phase IV 1 country Region Hovedstaden
COLCOT-T2D Recruiting

2024-516646-19-00 Phase III 6 countries Montreal Heart Institute
Anti-inflammatory drug to prevent complications in type 1 diabetes Recruiting

2025-521397-34-00 Phase III/IV 1 country Radboud universitair medisch centrum Stichting
Use of oral colchicine to determine restenosis in the superficial femoral artery - the COLSTENT study Recruiting

2023-508935-30-00 Phase III 1 country Uniwersytecki Szpital Kliniczny W Opolu
Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk: A randomized trial- LEADER PAD Recruiting

2024-512091-35-01 Phase III 4 countries Hamilton Health Sciences Corporation
RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Recruiting

2024-511580-28-02 Phase III 1 country Universitair Medisch Centrum Utrecht
COLchicine and Thiamine in Heart Failure due to Ischemic Heart Disease (COLT-HF) Recruiting

2023-506675-96-00 Phase III 1 country Hamilton Health Sciences Corporation
Colchicine for the treatment of hip and knee osteoarthritis. Recruiting

2024-511359-16-00 Phase III 1 country Sint Maartenskliniek
Colchicine for ischemia with no obstructive coronary artery disease and microvascular dysfunction Recruiting

2023-507981-17-00 Phase II 1 country Region Hovedstaden
ARGO Colchicine versus Placebo in Acute Myocarditis Patients to Reduce Late Gadolinium Enhancement Mass on Cardiac Magnetic Resonance and th… Recruiting

2024-514610-13-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Randomized controlled trial in patients on long-term colchicine with colchicine-resistant familial Mediterranean fever (FMF) to evaluate the… Recruiting

2023-506721-11-00 Phase III 1 country Assistance Publique Hopitaux De Paris
COLchicine in BElgium in patients with coronary artery disease after Percutaneous Coronary Intervention Recruiting

2023-505028-74-00 Phase III 1 country Az St-Jan Brugge-Oostende A.V.; Universitair Ziekenhuis Gent
The Colchicine heart failure preserved trial Recruiting

2023-506207-26-00 Phase III 1 country Gentofte Hospital
RIISC Recruiting

2024-513669-38-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controll… Ended

2022-502038-23-00 Phase II 1 country Gentofte Hospital
Pragmatic, randomized, multicentric, double-blind, controlled clinicial trial on the treatment of acute gout attacks with prednisolone versu… Ended

2024-514738-18-00 Phase IV 1 country Universitaetsmedizin Greifswald KöR
The COlchicine HypERtENsion Trial Ended

2024-511391-32-00 Phase II 1 country Gentofte Hospital

Showing 1–24 of 26 trials

← All drugs A–Z